Paper Details
- Home
- Paper Details
A dose-response trial of nebivolol in essential hypertension.
Author: DupontA G, GoyvaertsH, RobertsonJ I, Van NuetenL, VertommenC
Original Abstract of the Article :
A double-blind placebo-controlled dose-response trial of nebivolol, a cardioselective beta-blocking drug which also induces endothelium-dependent dilatation via nitric oxide, has been performed. Nebivolol reduced blood pressure (BP) in a dose dependent way, and was shown to be effective given once d...See full text at original site
Dr.Camel's Paper Summary Blogラクダ博士について
ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。
* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。
引用元:
https://doi.org/10.1038/sj.jhh.1000392
データ提供:米国国立医学図書館(NLM)
Nebivolol: A Promising Addition to the Antihypertensive Arsenal
The realm of hypertension research is vast, much like the endless expanse of the desert. We are always seeking new oases of effective and safe treatments to quench the thirst of high blood pressure. This study dives into the potential of nebivolol, a cardioselective beta-blocking drug with a unique twist – it also stimulates nitric oxide, a vital component in blood vessel dilation. The researchers conducted a double-blind, placebo-controlled dose-response trial to gauge the effects of nebivolol on blood pressure. The results showed a clear dose-dependent reduction in blood pressure with nebivolol, confirming its efficacy. Moreover, a single daily dose of 5mg proved to be an effective solution, with no noticeable advantage at 10mg. The icing on the cake? Nebivolol demonstrated a high level of tolerance, even at the higher dosage. This combination of efficacy and safety makes nebivolol a potentially valuable addition to the antihypertensive repertoire.
A Single Dose for Effective Blood Pressure Control
The study suggests that a single daily dose of 5mg nebivolol effectively controls blood pressure, with no significant difference between peak and trough drug levels. This implies a sustained effect throughout the day, a very important aspect for those seeking a convenient and effective management strategy. The researchers also noted that nebivolol achieved blood pressure control without the typical side effects of beta-blockade. This is a significant finding, as it suggests a potentially safer and more tolerable option for patients with hypertension.
Nebivolol: A Safe and Effective Option for Hypertension
This study presents a compelling case for nebivolol as a safe and effective treatment option for hypertension. The drug's unique mechanism of action, coupled with its favorable side effect profile, makes it an attractive alternative for patients seeking relief from high blood pressure. Imagine, a single dose that effectively controls blood pressure without causing the typical side effects of other medications! That's the promise of nebivolol. It is important to note that this study was relatively small and further research is needed to confirm these promising results. However, the findings suggest that nebivolol holds the potential to be a valuable tool in the fight against high blood pressure.
Dr.Camel's Conclusion
Nebivolol is a promising drug with the potential to be a safe and effective treatment for hypertension. Its unique mechanism of action, coupled with its favorable side effect profile, makes it a valuable addition to the antihypertensive arsenal. This study provides a solid foundation for further research to explore the full potential of nebivolol as a treatment option for hypertension.
Date :
- Date Completed 1997-06-24
- Date Revised 2019-11-02
Further Info :
Related Literature
English
This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.